Sorafenib treatment has the potential to downstage advanced hepatocellular carcinoma before liver resection
Personalized Medicine, Ahead of Print.
Source: Future Medicine: Personalized Medicine - Category: Genetics & Stem Cells Authors: Alessandra Bertacco Alessandro Vitale Claudia Mescoli Umberto Cillo Source Type: research
More News: Cancer & Oncology | Carcinoma | Genetics | Hepatocellular Carcinoma | Liver | Liver Cancer | Urology & Nephrology